Syndax Pharmaceuticals (SNDX) Insider Trading & Ownership $13.73 -0.09 (-0.65%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$13.74 +0.01 (+0.10%) As of 05/2/2025 05:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Syndax Pharmaceuticals (NASDAQ:SNDX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.10%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$25,037.50Number OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$336,086.50 Get SNDX Insider Trade Alerts Want to know when executives and insiders are buying or selling Syndax Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address SNDX Insider Buying and Selling by Quarter Syndax Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails2/10/2025Keith A GoldanCFOSell3,777$15.50$58,543.50 2/10/2025Michael A MetzgerCEOSell13,288$15.50$205,964.00 2/10/2025Neil GallagherInsiderSell4,618$15.50$71,579.00 6/14/2024Keith A GoldanCFOBuy1,250$20.03$25,037.50 (Data available from 1/1/2013 forward) SNDX Insider Trading Activity - Frequently Asked Questions Who is on Syndax Pharmaceuticals's Insider Roster? The list of insiders at Syndax Pharmaceuticals includes Briggs Morrison, Dennis Podlesak, Keith A Goldan, Keith Katkin, Michael A Metzger, Neil Gallagher, Peter Ordentlich, Pierre Legault, and William Meury. Learn more on insiders at SNDX. What percentage of Syndax Pharmaceuticals stock is owned by insiders? 4.10% of Syndax Pharmaceuticals stock is owned by insiders. Learn more on SNDX's insider holdings. Which Syndax Pharmaceuticals insiders have been buying company stock? The following insider purchased SNDX shares in the last 24 months: Keith A Goldan ($25,037.50). How much insider buying is happening at Syndax Pharmaceuticals? Insiders have purchased a total of 1,250 SNDX shares in the last 24 months for a total of $25,037.50 bought. Which Syndax Pharmaceuticals insiders have been selling company stock? The following insiders have sold SNDX shares in the last 24 months: Briggs Morrison ($4,294,997.30), Keith A Goldan ($71,416.37), Michael A Metzger ($205,964.00), Neil Gallagher ($71,579.00), and William Meury ($1,698,180.00). How much insider selling is happening at Syndax Pharmaceuticals? Insiders have sold a total of 316,680 Syndax Pharmaceuticals shares in the last 24 months for a total of $6,342,136.67 sold. Syndax Pharmaceuticals Key ExecutivesMr. Michael A. Metzger M.B.A. (Age 53)CEO & Director Compensation: $1.1M1 recent tradesDr. Peter Ordentlich B.Sc. (Age 55)Ph.D., Co-Founder & Chief Scientific Officer Dr. Richard A. Heyman Ph.D. (Age 67)Co-Founder Dr. Ronald M. Evans Ph.D. (Age 75)Co-Founder, Advisor and Chair of Scientific Advisory Board Dr. Michael Downes Ph.D.Co-FounderSharon KlahreVice President of Investor Relations & CommunicationsMr. Kevin McManus (Age 55)Chief People Officer Dr. Joseph Paul Eder M.D.Member of Scientific Advisory Board & Chief Medical OfficerDr. Anjali Ganguli Ph.D. (Age 47)Chief Business Officer Compensation: $450.58kMr. Steven ClosterChief Commercial Officer More Insider Trading Tools from MarketBeat Related Companies PCVX Insider Selling RYTM Insider Selling PTCT Insider Selling RNA Insider Selling ZLAB Insider Selling RARE Insider Selling ACLX Insider Selling SWTX Insider Selling OGN Insider Selling MRUS Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles McDonald’s Insiders Sell Shares! Investors Should Do the Opposite5 Mid-Cap Stocks Insiders Are Buying This YearInsider Buying in This Stock Reiterates Analysts Bullish OutlookBeware of BigBear.ai: Insiders Are Selling—Should You?XPO Buying $50 Million of Its Own Stock: Here's Why This page (NASDAQ:SNDX) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredWhat President Trump’s Executive Order 14154 means for your moneyNearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a f...Stansberry Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Syndax Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Syndax Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
